# GDPR Compliance Audit - Executive Summary
## Subdomain Architecture Assessment for Massava

**Date:** November 4, 2025  
**Auditor:** Security & Privacy Auditor Agent  
**Overall Rating:** **6.5/10** ⚠️  
**Status:** **AMBER - SIGNIFICANT GAPS REQUIRING REMEDIATION**

---

## TL;DR - Management Summary

**Question:** Is the proposed subdomain architecture (`massava.app` vs `business.massava.app`) sufficient for GDPR compliance, particularly for Art. 9 health data processing?

**Answer:** **NO** - Subdomain separation is a good security enhancement but NOT sufficient alone. Critical compliance gaps exist.

### Critical Blockers (Must Fix Before Launch)

1. 🔴 **Health data encryption MISSING** (Art. 9 violation) - **HIGH RISK**
2. 🔴 **Cookie consent banner MISSING** (ePrivacy violation) - **HIGH RISK**
3. 🔴 **Data export/deletion endpoints MISSING** (Art. 15-17 GDPR) - **HIGH RISK**
4. 🔴 **IP anonymization MISSING** (Art. 25 GDPR) - **MEDIUM RISK**
5. 🔴 **Hetzner AVV not documented** (Art. 28 GDPR) - **MEDIUM RISK**

**Estimated Effort to Compliance:** **10-14 days** (full-time development)  
**Regulatory Risk:** **HIGH** - Art. 9 violations can result in fines up to €20M or 4% of revenue

---

## What Works Well ✅

1. **bcrypt with 12 rounds** (strong password hashing)
2. **Comprehensive security headers** (CSP, HSTS, X-Frame-Options)
3. **Rate limiting on authentication** (5 attempts/15min)
4. **Privacy policy comprehensive** (covers Art. 13-14)
5. **No npm vulnerabilities** (clean audit)
6. **Role-based access control** (RBAC)
7. **JWT session strategy** (30-day expiration)
8. **Audit logging schema** (exists, needs IP anonymization)

---

## Critical Gaps ❌

### 1. Art. 9 Health Data - NOT COMPLIANT 🔴

**Problem:** Booking messages containing health information stored in **plain text**.

**Current:**
```typescript
message: validated.message || null, // ❌ Plain text in database
```

**Required:**
```typescript
message: encryptHealthData(validated.message), // ✅ AES-256-GCM encrypted
```

**Risk:** **CRITICAL** - Art. 9 violations: up to €20M or 4% of global revenue  
**Effort:** 2-3 days  
**Industry Standard:** Doctolib, Jameda both use AES-256 encryption

---

### 2. Cookie Consent - NOT COMPLIANT 🔴

**Problem:** No cookie consent banner. Session cookies set without user consent.

**Current:** ❌ No implementation  
**Required:** ✅ GDPR-compliant cookie banner with opt-in before tracking

**Risk:** **HIGH** - ePrivacy Directive violation  
**Effort:** 1-2 days  

---

### 3. Data Subject Rights - NOT COMPLIANT 🔴

**Problem:** Privacy policy links to `/api/user/export` and `/api/user/delete` - both return 404.

**Missing Endpoints:**
- ❌ `/api/user/export` (Art. 15 - Right to Access)
- ❌ `/api/user/export/csv` (Art. 20 - Data Portability)
- ❌ `/api/user/delete` (Art. 17 - Right to Erasure)

**Risk:** **HIGH** - Users can complain to data protection authority  
**Effort:** 2-3 days

---

### 4. IP Anonymization - NOT COMPLIANT 🔴

**Problem:** Audit logs store full IP addresses (e.g., `192.168.1.100`).

**Required:** Anonymize to `192.168.1.0` (remove last octet)

**Risk:** **MEDIUM** - Art. 25 Privacy by Design violation  
**Effort:** 0.5 days

---

### 5. Hetzner AVV - NOT DOCUMENTED 🟡

**Problem:** No evidence of signed AVV (Auftragsverarbeitungsvertrag) with Hetzner.

**Required Actions:**
1. Sign Hetzner AVV: https://www.hetzner.com/legal/avv
2. Store signed PDF in `/docs/gdpr/avv/hetzner-avv-signed.pdf`
3. Update privacy policy with AVV status

**Risk:** **MEDIUM** - Art. 28 violation  
**Effort:** 0.5 days (admin work)

---

## Subdomain Architecture Analysis

### Technical Isolation Score: **2.2/5 (44%)**

| Mechanism | Rating | Notes |
|-----------|--------|-------|
| Cookie Domain Scoping | 3/5 | Browser-enforced, but needs explicit configuration |
| Database Isolation | 2/5 | Shared database, role-based filtering only |
| Network Isolation | 1/5 | Same Next.js app, same container |
| Access Control | 4/5 | RBAC implemented well |
| Audit Trail | 3/5 | Exists, but IP not anonymized |
| Encryption | **0/5** | **Health data NOT encrypted** 🔴 |

### Is Subdomain Separation Sufficient for Art. 9?

**NO** - Subdomain separation provides:
- ✅ Session isolation (good UX)
- ✅ Clear role separation (easier to audit)
- ✅ Reduced attack surface

But does NOT provide:
- ❌ Data encryption (must be implemented separately)
- ❌ IP anonymization (must be implemented separately)
- ❌ Cookie consent (must be implemented separately)
- ❌ Data subject rights (must be implemented separately)

**Verdict:** Subdomain architecture is a **good security enhancement** but requires additional compliance work.

---

## OWASP Top 10 Compliance: **7.7/10** ✅

- A01: Broken Access Control - **8/10** ✅
- A02: Cryptographic Failures - **5/10** ⚠️ (health data not encrypted)
- A03: Injection - **9/10** ✅ (Prisma ORM)
- A04: Insecure Design - **7/10** ✅
- A05: Security Misconfiguration - **8/10** ✅
- A06: Vulnerable Components - **10/10** ✅ (clean npm audit)
- A07: Authentication Failures - **7/10** ✅
- A08: Data Integrity Failures - **8/10** ✅
- A09: Logging Failures - **6/10** ⚠️ (IP not anonymized)
- A10: SSRF - **9/10** ✅

---

## Comparison with Industry Standards

| Feature | Doctolib | Jameda | Massava (Current) | Massava (Required) |
|---------|----------|--------|-------------------|-------------------|
| **Health Data Encryption** | ✅ E2E | ✅ AES-256 | ❌ Plain text | ✅ AES-256-GCM |
| **Cookie Consent** | ✅ Yes | ✅ Yes | ❌ None | ✅ Required |
| **Data Export** | ✅ JSON+PDF | ✅ Yes | ❌ None | ✅ JSON+CSV |
| **AVV Documentation** | ✅ Public | ✅ Public | ⚠️ Unknown | ✅ Required |
| **ISO 27001 Certified** | ✅ Yes | ✅ Yes | ❌ No | ⚠️ Consider |

**Current Position:** **Below industry standard**  
**After Fixes:** **On par with industry leaders**

---

## Certification Readiness

### Is This Architecture Audit-Ready?

**NO** ❌

**Blocking Issues:**
1. Health data encryption
2. Cookie consent implementation
3. Data export/deletion endpoints
4. IP anonymization
5. AVV documentation

**Time to Audit-Ready:** **2-3 weeks** (with focused development)

---

## Required Improvements - Priority Matrix

### Immediate (Before Launch) - **6-9 days**

| Priority | Issue | Effort | Risk if Skipped |
|----------|-------|--------|-----------------|
| **P1** | Encrypt Art. 9 health data | 2-3 days | 🔴 CRITICAL |
| **P2** | Cookie consent banner | 1-2 days | 🔴 HIGH |
| **P3** | Data subject rights endpoints | 2-3 days | 🔴 HIGH |
| **P4** | IP anonymization | 0.5 days | 🟡 MEDIUM |
| **P5** | Hetzner AVV documentation | 0.5 days | 🟡 MEDIUM |

### Short-Term (Within 1 Month) - **4-5 days**

| Priority | Issue | Effort | Risk if Skipped |
|----------|-------|--------|-----------------|
| **P6** | Data retention automation | 1-2 days | 🟡 MEDIUM |
| **P7** | Breach notification plan | 1 day | 🟡 MEDIUM |
| **P8** | Enhanced audit logging | 1 day | 🟢 LOW |
| **P9** | Cookie domain configuration | 1 day | 🟡 MEDIUM |

### Long-Term (Nice-to-Have)

- MFA support (3-5 days)
- Automated security scanning (ongoing)
- ISO 27001 certification (3-6 months)

---

## Recommendations

### Architecture Decision

✅ **APPROVE subdomain architecture** (`massava.app` vs `business.massava.app`)

**Why:**
- Good security enhancement (defense in depth)
- Clear separation of concerns (easier to audit)
- Better UX (business users get dedicated portal)
- Reduced risk (breach isolation)

**But:**
- Must implement critical compliance gaps (encryption, consent, data rights)
- Subdomain separation alone is NOT sufficient for GDPR compliance
- Additional work required regardless of architecture choice

### Development Roadmap

**Week 1 (P1-P3):**
1. Implement health data encryption (AES-256-GCM)
2. Implement cookie consent banner
3. Implement data export/deletion endpoints

**Week 2 (P4-P9):**
1. IP anonymization
2. AVV documentation
3. Data retention automation
4. Breach notification plan
5. Cookie domain configuration

**Week 3:**
1. Testing and validation
2. External GDPR audit
3. Documentation updates

**Week 4:**
1. Security review
2. Compliance documentation
3. Launch preparation

---

## Financial Impact

### Cost of Non-Compliance

**Regulatory Fines (GDPR Art. 83):**
- Art. 9 violation: Up to **€20M or 4% of global revenue**
- ePrivacy violation: Up to **€10M or 2% of global revenue**
- Art. 15-17 violation: Up to **€10M or 2% of global revenue**

**Reputational Damage:**
- Customer trust loss
- Negative press coverage
- Competitor advantage

### Cost of Compliance

**Development Work:**
- 10-14 days developer time: ~€8,000-12,000 (at €800/day)

**External Audit:**
- GDPR compliance audit: €5,000-15,000
- ISO 27001 certification (optional): €20,000-50,000

**Total Immediate Investment:** €13,000-27,000

**ROI:** Avoiding a single €100,000 fine = **5x-10x return**

---

## Conclusion

### Summary

The proposed subdomain architecture is a **solid foundation** but has **critical GDPR compliance gaps**. The architecture provides good session isolation and role separation, but **does not address the core compliance requirements** for Art. 9 health data processing.

### Key Takeaways

1. **Subdomain separation ≠ GDPR compliance**
2. **Health data encryption is MANDATORY** (not optional)
3. **Cookie consent is MANDATORY** (ePrivacy Directive)
4. **Data subject rights must be implemented** (Art. 15-17)
5. **10-14 days of focused work** required for full compliance

### Final Verdict

**Status:** **AMBER - PROCEED with caution**

**Recommendation:**
- ✅ Approve subdomain architecture
- 🔴 Block launch until critical gaps fixed
- 📅 Allocate 2-3 weeks for compliance work
- 🔍 Schedule external audit after implementation

**Expected Rating After Fixes:** **9.5/10** ✅ (audit-ready)

---

**Next Steps:**

1. [ ] Review this report with development team
2. [ ] Prioritize P1-P5 immediate fixes
3. [ ] Allocate developer resources (10-14 days)
4. [ ] Sign Hetzner AVV (admin work)
5. [ ] Schedule external GDPR audit (post-implementation)
6. [ ] Update project timeline to account for compliance work

---

**Contact:**
- Technical Questions: development@rnltlabs.de
- Compliance Questions: datenschutz@massava.com
- Regulatory Inquiries: legal@rnltlabs.de

---

**Document Classification:** Internal Use Only  
**Review Date:** After implementing critical fixes (estimated 2-3 weeks)
